| Product Code: ETC9971245 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States continues to rely on imports of needle-based biopsy guns, with key suppliers in 2024 being Mexico, Costa Rica, Ireland, Japan, and Malaysia. The market shows high concentration with a Herfindahl-Hirschman Index (HHI) remaining elevated in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 is a robust 12.32%, indicating sustained demand for these medical devices. Additionally, the growth rate from 2023 to 2024 spiked at 17.55%, reflecting a significant uptick in import shipments. These trends suggest a thriving market for needle-based biopsy guns in the United States.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Needle Based Biopsy Gun Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Needle Based Biopsy Gun Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Needle Based Biopsy Gun Market - Industry Life Cycle |
3.4 United States (US) Needle Based Biopsy Gun Market - Porter's Five Forces |
3.5 United States (US) Needle Based Biopsy Gun Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.6 United States (US) Needle Based Biopsy Gun Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 United States (US) Needle Based Biopsy Gun Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer and demand for minimally invasive biopsy procedures |
4.2.2 Technological advancements in needle-based biopsy guns leading to improved accuracy and efficiency |
4.2.3 Growing awareness about early cancer detection and screening programs |
4.3 Market Restraints |
4.3.1 High cost associated with needle-based biopsy guns and procedures |
4.3.2 Stringent regulatory requirements for product approval and market entry |
4.3.3 Limited availability of skilled healthcare professionals proficient in performing biopsies |
5 United States (US) Needle Based Biopsy Gun Market Trends |
6 United States (US) Needle Based Biopsy Gun Market, By Types |
6.1 United States (US) Needle Based Biopsy Gun Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Needle Based Biopsy Gun Market Revenues & Volume, By Product Type, 2022 - 2032F |
6.1.3 United States (US) Needle Based Biopsy Gun Market Revenues & Volume, By Disposable, 2022 - 2032F |
6.1.4 United States (US) Needle Based Biopsy Gun Market Revenues & Volume, By Reusable, 2022 - 2032F |
6.2 United States (US) Needle Based Biopsy Gun Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Needle Based Biopsy Gun Market Revenues & Volume, By vacuum-assisted biopsy devices (VAB), 2022 - 2032F |
6.2.3 United States (US) Needle Based Biopsy Gun Market Revenues & Volume, By core needle biopsy devices (CNB), 2022 - 2032F |
6.2.4 United States (US) Needle Based Biopsy Gun Market Revenues & Volume, By fine needle aspiration biopsy devices (FNAB), 2022 - 2032F |
7 United States (US) Needle Based Biopsy Gun Market Import-Export Trade Statistics |
7.1 United States (US) Needle Based Biopsy Gun Market Export to Major Countries |
7.2 United States (US) Needle Based Biopsy Gun Market Imports from Major Countries |
8 United States (US) Needle Based Biopsy Gun Market Key Performance Indicators |
8.1 Average biopsy procedure time using needle-based biopsy guns |
8.2 Adoption rate of advanced needle-based biopsy gun technologies |
8.3 Number of training programs or certifications for healthcare professionals in biopsy procedures |
8.4 Patient satisfaction rates with needle-based biopsy procedures |
8.5 Frequency of repeat biopsies due to inconclusive results |
9 United States (US) Needle Based Biopsy Gun Market - Opportunity Assessment |
9.1 United States (US) Needle Based Biopsy Gun Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.2 United States (US) Needle Based Biopsy Gun Market Opportunity Assessment, By Application, 2022 & 2032F |
10 United States (US) Needle Based Biopsy Gun Market - Competitive Landscape |
10.1 United States (US) Needle Based Biopsy Gun Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Needle Based Biopsy Gun Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here